{{expand|time=2013-03-28T04:33:49+00:00}}
{{Infobox company|
  name   = 梯瓦制药工业有限公司|
  logo   = [[Image:TevaPharm.svg|200px]]|
  type   = 公开
  traded_as = {{NYSE|TEVA}}<br>{{TASE|TEVA}}|
  foundation     = 1901|
  location_city  =  [[Petah_Tikva|Petah Tikva]] |
  location_country = [[以色列|以色列]]|
  key_people = [[Jeremy_Levin|Jeremy Levin]], 总裁兼首席执行官<ref name=bloomberg2jan2012/><br />[[Phillip_Frost|Dr. Phillip Frost]], 董事长<br />Eyal Desheh, 首席财务官|
  industry       = 制药|
| revenue = {{profit}}$20,3 billion [[United_States_dollar|USD]] ([[fiscal_year|FY]] 2012)|
| operating_income = {{profit}}$2,2 billion [[United_States_dollar|USD]] ([[fiscal_year|FY]] 2012)
| net_income = {{profit}}$1,9 billion [[United_States_dollar|USD]] ([[fiscal_year|FY]] 2012)|
| num_employees = 46,000人 (2012)
|  homepage       = [http://www.tevapharm.com/ tevapharm.com]
}}
[[File:TevaCanada3.jpg|thumb]]
'''梯瓦制药工业有限公司'''（{{lang-he|טבע תעשיות פרמצבטיות בע"מ}}）是一家跨国[[制药公司|制药公司]]，总部位于[[以色列|以色列]][[佩塔提克瓦|佩塔提克瓦]]，专精于[[仿制药|仿制药]]、专利药和医药原料的生产与销售。它是世界上最大的仿制药厂<ref name=hollisfiercepharma2010/>，亦是第15大制药企业<ref name=biojerusalem/>。

==历史==
2015年7月27日以色列梯瓦同意以405億美元(約3159億港元)收購[[愛力根|愛力根]]（Allergan）旗下非專利藥業務，該交易將使Teva躋身全球10大製藥企業行列。Teva在聲明中稱，將支付337.5億美元現金及價值67.5億美元的Teva股票，

== 参考资料 ==
{{Reflist|2|refs=

<ref name=biojerusalem>{{cite web |url=http://www.biojerusalem.org.il/database_company.asp?ID=76 |title=Teva Pharmaceutical Industries—Jerusalem |work=Database |publisher=[[BioJerusalem|BioJerusalem]] |location=Jerusalem, Israel |archiveurl=https://www.webcitation.org/5yXPfzOwL?url=http://www.biojerusalem.org.il/database_company.asp?ID=76 |archivedate=2011-05-08 |accessdate= |dead-url=yes }}</ref>

<ref name=hollisfiercepharma2010>{{cite web |url=http://www.fiercepharma.com/special-reports/top-10-generic-drug-companies-2010/teva-top-10-generic-drug-companies-2010 |title=Teva – Top 10 Generic Drug Companies 2010 |first=Liz Jones |last=Hollis |date=August 10, 2010 |work=FiercePharma |publisher=[[FierceMarkets|FierceMarkets]] |location=Washington, DC, United States |accessdate=November 3, 2010 |archiveurl=https://www.webcitation.org/5yXPMLkBa?url=http://www.fiercepharma.com/special-reports/top-10-generic-drug-companies-2010/teva-top-10-generic-drug-companies-2010 |archivedate=2011-05-08 |dead-url=no }}</ref>

<ref name=bloomberg2jan2012>{{Citation |author=[[Bloomberg_News|Bloomberg News]] |publication-date=January 2, 2012 |title=Teva Names a New Chief Executive |newspaper=[[The_New_York_Times|The New York Times]] |at=Business Day (nytimes.com) |url=http://www.nytimes.com/2012/01/03/business/teva-names-a-new-chief-executive.html |accessdate=January 3, 2012 |archive-date=2012-04-27 |archive-url=https://web.archive.org/web/20120427040309/http://www.nytimes.com/2012/01/03/business/teva-names-a-new-chief-executive.html |dead-url=no }}<br />Jeremy Levin will replace Shlomo Yanai as Chief Executive Officer upon Mr. Yanai's retirement in May 2012.</ref>

}}

==外部链接==
*[http://www.tevapharm.com/ Teva Pharmaceutical Industries Official website] {{Wayback|url=http://www.tevapharm.com/ |date=20141009033321 }}
*[http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/272006/354138/article.pdf Pharmaceutical Executive] {{Wayback|url=http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/272006/354138/article.pdf |date=20140107214604 }} (PDF)
*{{cite web |url=http://www.tevausa.com/default.aspx?pageid=75
 |title=Recent Product Launches, Teva Pharmaceuticals USA |accessdate=February 21, 2008 }}<!-- Strange entry, reported to Ceyockey's talk page 2014-03-12 -->
*[http://articles.economictimes.indiatimes.com/2012-01-03/news/30584630_1_teva-pharmaceutical-industries-shlomo-yanai-cephalon The Economic Times] {{Wayback|url=http://articles.economictimes.indiatimes.com/2012-01-03/news/30584630_1_teva-pharmaceutical-industries-shlomo-yanai-cephalon |date=20160916095113 }}
{{authority control}}
[[Category:以色列制药公司|Category:以色列制药公司]]
[[Category:以色列品牌|Category:以色列品牌]]
[[Category:1901年成立的公司|Category:1901年成立的公司]]